WO2015166418A3 - Composición farmacéutica para el tratamiento de alopatías relacionadas con el dolor, usando como agente activo al ketorolaco trometamina y clorhidrato de tramadol - Google Patents

Composición farmacéutica para el tratamiento de alopatías relacionadas con el dolor, usando como agente activo al ketorolaco trometamina y clorhidrato de tramadol Download PDF

Info

Publication number
WO2015166418A3
WO2015166418A3 PCT/IB2015/053097 IB2015053097W WO2015166418A3 WO 2015166418 A3 WO2015166418 A3 WO 2015166418A3 IB 2015053097 W IB2015053097 W IB 2015053097W WO 2015166418 A3 WO2015166418 A3 WO 2015166418A3
Authority
WO
WIPO (PCT)
Prior art keywords
allopathic
pain
treatment
pharmaceutical composition
tramadol hydrochloride
Prior art date
Application number
PCT/IB2015/053097
Other languages
English (en)
French (fr)
Other versions
WO2015166418A2 (es
Inventor
Oliver Daniel WALLS FLORES
Ramón RODRÍGUEZ HERNÁNDEZ
Eduardo BARRENA HERNÁNDEZ
Original Assignee
Laboratorios Liomont, S.A. De C.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54359444&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO2015166418(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Laboratorios Liomont, S.A. De C.V. filed Critical Laboratorios Liomont, S.A. De C.V.
Publication of WO2015166418A2 publication Critical patent/WO2015166418A2/es
Publication of WO2015166418A3 publication Critical patent/WO2015166418A3/es
Priority to SV2016005308A priority Critical patent/SV2016005308A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Una composición farmacéutica inyectable de la combinación de ketrolaco trometamina / clorhidrato de tramadol para el tratamiento de alopatías relacionadas con el dolor (de moderado a severo), analgésico, antiinflamatorio, fiebre o antipirética, entre otros utilizando menos excipientes que no contribuyen con el efecto terapéutico deseado.
PCT/IB2015/053097 2014-04-29 2015-04-29 Composición farmacéutica para el tratamiento de alopatías relacionadas con el dolor, usando como agente activo al ketorolaco trometamina y clorhidrato de tramadol WO2015166418A2 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SV2016005308A SV2016005308A (es) 2014-04-29 2016-10-28 Composiciã“n farmacã‰utica para el tratamiento de alopatã�as relacionadas con el dolor, usando como agente activo al ketorolaco trometamina y clorhidrato de tramadol

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MX2014005152A MX2014005152A (es) 2014-04-29 2014-04-29 Composicion farmaceutica para el tratamiento de alopatias relacionadas con el dolor, usando como agente activo al ketorolaco trometamina y clorhidrato de tramadol.
MXMX/A/2014/005152 2014-04-29

Publications (2)

Publication Number Publication Date
WO2015166418A2 WO2015166418A2 (es) 2015-11-05
WO2015166418A3 true WO2015166418A3 (es) 2016-01-07

Family

ID=54359444

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2015/053097 WO2015166418A2 (es) 2014-04-29 2015-04-29 Composición farmacéutica para el tratamiento de alopatías relacionadas con el dolor, usando como agente activo al ketorolaco trometamina y clorhidrato de tramadol

Country Status (4)

Country Link
CL (1) CL2016002655A1 (es)
MX (1) MX2014005152A (es)
SV (1) SV2016005308A (es)
WO (1) WO2015166418A2 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019122982A1 (en) 2017-12-21 2019-06-27 Grünenthal GmbH Pharmaceutical combination in a bilayer tablet form comprising ketorolac tromethamine and tramadol hydrochloride, and its use in pain treatment
MX2018000963A (es) 2018-01-22 2018-12-13 Federico Amezcua Amezcua Composicion farmaceutica sinergica del enantiomero activo s-ketorolaco trometamina y clorhidrato de tramadol.

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03012048A (es) * 2003-12-19 2005-06-23 Victor Guillermo Alvarez Ochoa Composiciones farmaceuticas en solucion inyectable que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor.
WO2012049550A1 (es) * 2010-10-12 2012-04-19 World-Trade Import-Export Wtie, Ag Composicíon farmacéutica liquida para el tratamiento y prevención del dolor
WO2013163142A1 (en) * 2012-04-25 2013-10-31 Yung Shin Pharm. Ind. Co., Ltd. Liquid pharmaceutical formulation containing ketorolac and tramadol

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03012048A (es) * 2003-12-19 2005-06-23 Victor Guillermo Alvarez Ochoa Composiciones farmaceuticas en solucion inyectable que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor.
WO2012049550A1 (es) * 2010-10-12 2012-04-19 World-Trade Import-Export Wtie, Ag Composicíon farmacéutica liquida para el tratamiento y prevención del dolor
WO2013163142A1 (en) * 2012-04-25 2013-10-31 Yung Shin Pharm. Ind. Co., Ltd. Liquid pharmaceutical formulation containing ketorolac and tramadol

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
"GAMMADOL, prospecto, efectos adversos, preguntas frecuentes;", 25 November 2013 (2013-11-25), Retrieved from the Internet <URL:http://www.doctoralia.com.mx/medicamento/gammadol-54051> [retrieved on 20151020] *
LIN T F ET AL.: "Compatibility and Stability of Binary Mixtures of Ketorolac Tromethamine and Tramadol Hydrochloride Injection Concentrate and Diluted Infusion Solution.", ACTA ANAESTHESIOLOGICA TAIWAN ICA, vol. 48, no. 3, 1 September 2010 (2010-09-01), AMSTERDAM, NL, pages 117 - 121, XP027306392, ISSN: 1875-4597 *
PIERI M ET AL.: "Control of acute pain after major abdominal surgery in 585 patients given tramadol and ketorolac by intravenous infusion..", DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH SWITZERLAND, vol. 28, no. 2-3, 2002, pages 113 - 118, ISSN: 0378-6501 *

Also Published As

Publication number Publication date
CL2016002655A1 (es) 2017-02-17
SV2016005308A (es) 2017-05-15
WO2015166418A2 (es) 2015-11-05
MX2014005152A (es) 2015-10-28

Similar Documents

Publication Publication Date Title
PH12020500066A1 (en) Carboxamides as modulators of sodium channels
EA201892395A1 (ru) Лекарственные составы ингибитора lsd1
MX2021004110A (es) Composiciones farmaceuticas que comprenden n-(3,5- dimetoxifenil)-n&#39;-(1-metiletil)-n-[3-(1-metil-1h- pirazol-4-il)quinoxalin-6-il]etano-1,2-diamina.
WO2015077503A8 (en) Autotaxin inhibitor compounds
WO2016004305A3 (en) Inhibitors of bruton&#39;s tyrosine kinase
EA201990424A1 (ru) Спиролактамовые модуляторы nmda-рецептора и их применение
EA201990428A1 (ru) Спиролактамовые модуляторы nmda-рецептора и их применение
EA201990425A1 (ru) Спиролактамовые и бис-спиролактамовые модуляторы nmda-рецептора и их применение
MX2018000419A (es) Derivados de amida sustituida que tienen actividad multimodal contra el dolor.
MX2022001796A (es) Metodos y composiciones para inhibir los sintomas asociados con la veisalgia.
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
WO2015166418A3 (es) Composición farmacéutica para el tratamiento de alopatías relacionadas con el dolor, usando como agente activo al ketorolaco trometamina y clorhidrato de tramadol
WO2015166419A3 (es) Proceso de obtención y composición farmacéutica de ketorolaco trometamina y clorhidrato de tramadol sublingual usado para el dolor
EP3777849A4 (en) PHARMACEUTICAL COMPOSITION, COMPRISING POLMACOXIB AND PREGABALIN, FOR THE TREATMENT OF PAIN
MX2018006631A (es) Compuesto para uso en la prevencion y tratamiento de enfermedades neurodegenerativas.
WO2016144706A3 (en) Autotaxin inhibitor compounds and uses thereof
EP3838270A4 (en) SYNERGISTIC PHARMACEUTICAL COMPOSITION WITH ACECLOFENAC AND BETAMETHASONE FOR THE TREATMENT OF PAIN IN LOCALIZED FORMS OF RHEUMATIC DISEASES
MX2018000418A (es) Derivados de amida que tienen actividad multimodal contra el dolor.
TW201611830A (en) Pharmaceutical formulation for reducing bladder spasms and method of use thereof
WO2019132729A3 (ru) Фармацевтические композиции на основе ментилового эфира индометацина и его применение
MX2013008993A (es) Sistema de liberacion modificada en tres fases de un antiinflamatorio no esteroide.
EA202090268A1 (ru) Карбоксамиды в качестве модуляторов натриевых каналов
EA201990426A1 (ru) Спиро-лактамовые модуляторы nmda-рецептора и их применение
MX2016012553A (es) Composiciones farmaceuticas de mazindol con metformina para perdida de peso.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15785948

Country of ref document: EP

Kind code of ref document: A2

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15785948

Country of ref document: EP

Kind code of ref document: A2